PEPperPRINT launches new peptide microarray platform on 15th anniversary
Ella Day | June 11, 2025 | News story | Biotech/start-up, Research and Development, Sales and Marketing | Devices, PEPperPRINT, biotech research, peptide microarray platform
German biotech PEPperPRINT has marked its 15th anniversary with the launch of a new peptide microarray platform, combinatorial laser-induced forward transfer (cLIFT), designed to significantly enhance peptide printing capabilities and enable a wider range of biomedical research applications.
Developed in partnership with researchers at the Max Planck Institute of Colloids and Interfaces and Karlsruhe Institute of Technology, both in Germany, cLIFT builds on PEPperPRINT’s proprietary laser-printing technology. It offers five times higher density – up to 50,000 peptide spots per glass slide – and improved chemical compatibility, allowing for the integration of post-translational modifications such as phosphorylation and glycosylation, as well as non-natural amino acids.
“cLIFT opens the door to research opportunities that were previously out of reach,” said Volker Stadler, CEO of PEPperPRINT. “From studying the effects of molecular modifications to building full D-peptide libraries, this technology helps scientists push scientific boundaries.”
The cLIFT platform uses a high-resolution laser to place amino acids in layers with great precision, creating complex and highly customisable microarrays. It is expected to support epitope mapping, vaccine development, immunogenicity risk assessment and therapeutic antibody discovery.
PEPperPRINT will host a webinar on 24 June to introduce the technology to researchers and discuss its applications.
Based in Heidelberg, Germany, PEPperPRINT provides peptide microarrays and analysis services to academic and industry partners worldwide.
Ella Day
11/6/25
